Can a daily powder boost baby gut bacteria and prevent future allergies?

NCT ID NCT06746285

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a daily synbiotic supplement—a mix of beneficial bacteria and prebiotics—can safely improve gut health in infants aged 2 to 24 months. 200 babies will receive either the supplement or a placebo for one month. Researchers will check for tummy troubles and changes in gut bacteria to see if the supplement is well-tolerated and shifts the microbiome.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
synbiotic supplement (Bifidobacterium strains and human milk oligosaccharides)
What this could lead to
If successful, this could show that a daily synbiotic helps establish healthy gut bacteria in infants, potentially reducing future allergy or immune issues.
What could go wrong
This is an early-stage trial with only 200 infants, focused on safety and microbiome changes, not on preventing disease. Results may not lead to a proven treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL TOLERANCE OF PROBIOTICS IN INFANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Persephone Biosciences

    San Diego, California, 92121, United States